Page 3 - Jeffreym Jonas News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jeffreym jonas. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jeffreym Jonas Today - Breaking & Trending Today

Karuna Therapeutics (NASDAQ:KRTX) PT Lowered to $235.00 at Royal Bank of Canada

Karuna Therapeutics (NASDAQ:KRTX – Free Report) had its price objective decreased by Royal Bank of Canada from $249.00 to $235.00 in a research note published on Friday, Benzinga reports. Royal Bank of Canada currently has an outperform rating on the stock. Several other equities analysts have also recently weighed in on the stock. Morgan Stanley […] ....

United States , Peter Jeffrey Conn , Jeffreym Jonas , Eric Elenko , Lauriej Olson , Andrew Miller , Ballentine Partners , Calamos Advisors , Fiera Capital Corp , Karuna Therapeutics Inc , Royal Bank , Securities Exchange Commission , Morgan Stanley , Jpmorgan Chase Co , Financial Services Group Inc , China Universal Asset Management Co , Karuna Therapeutics , Free Report , Moderate Buy , Get Free Report , Director Laurie , Director Jeffrey , Exchange Commission , Services Group , Universal Asset Management , Capital Corp ,

Karuna Therapeutics' (KRTX) Buy Rating Reiterated at HC Wainwright

HC Wainwright reaffirmed their buy rating on shares of Karuna Therapeutics (NASDAQ:KRTX – Free Report) in a research note published on Friday, Benzinga reports. They currently have a $300.00 price target on the stock. Several other analysts also recently issued reports on KRTX. 58.com reaffirmed a maintains rating on shares of Karuna Therapeutics in a […] ....

New Zealand General , New Zealand , Troya Ignelzi , Jeffreym Jonas , Pricet Rowe Associates Inc , Blackrock Inc , Securities Exchange Commission , Morgan Stanley , Vanguard Group Inc , Karuna Therapeutics Inc , Jpmorgan Chase Co , Wellington Management Group , Karuna Therapeutics , Free Report , Moderate Buy , Get Free Report , Director Jeffrey , Exchange Commission , Management Group , Karuna Therapeutics Daily , Nasdaq Krtx , Reiterated Rating , Hc Wainwright ,

Karuna Therapeutics (NASDAQ:KRTX) Given "Buy" Rating at HC Wainwright

HC Wainwright reiterated their buy rating on shares of Karuna Therapeutics (NASDAQ:KRTX – Free Report) in a report published on Friday morning, Benzinga reports. HC Wainwright currently has a $300.00 price target on the stock. KRTX has been the topic of several other research reports. JPMorgan Chase & Co. lowered their price objective on shares […] ....

Jeffreym Jonas , Troya Ignelzi , Ballentine Partners , Calamos Advisors , Karuna Therapeutics Inc , China Universal Asset Management Co , Jpmorgan Chase Co , Securities Exchange Commission , Financial Services Group Inc , Morgan Stanley , Fiera Capital Corp , Karuna Therapeutics , Free Report , Moderate Buy , Therapeutics Trading Down , Get Free Report , Director Jeffrey , Exchange Commission , Services Group , Universal Asset Management , Capital Corp , Karuna Therapeutics Daily , Nasdaq Krtx , Reiterated Rating , Hc Wainwright ,

Karuna Therapeutics (NASDAQ:KRTX) Price Target Lowered to $235.00 at Royal Bank of Canada

Karuna Therapeutics (NASDAQ:KRTX) Price Target Lowered to $235.00 at Royal Bank of Canada
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , Jeffreym Jonas , Lauriej Olson , Jpmorgan Chase Co , Royal Bank , Securities Exchange Commission , York Mellon Corp , Cambridge Investment Research Advisors Inc , Morgan Stanley , Karuna Therapeutics Inc , Metlife Investment Management , Karuna Therapeutics , Free Report , Moderate Buy , Therapeutics Trading Down , Get Free Report , Director Jeffrey , Exchange Commission , Director Laurie , New York Mellon Corp , Investment Research Advisors , Life Investment Management , Rhumbline Advisers , Karuna Therapeutics Daily ,

Morgan Stanley Reaffirms Overweight Rating for Karuna Therapeutics (NASDAQ:KRTX)

Morgan Stanley Reaffirms Overweight Rating for Karuna Therapeutics (NASDAQ:KRTX)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Troya Ignelzi , Jeffreym Jonas , Morgan Stanley , First Horizon Advisors Inc , Jpmorgan Chase Co , Almanack Investment Partners , Karuna Therapeutics Inc , Securities Exchange Commission , Advisors Inc , Royal Bank , Karuna Therapeutics Company Profile , Karuna Therapeutics , Get Free Report , Therapeutics Trading Down , Exchange Commission , Director Jeffrey , Horizon Advisors , Karuna Therapeutics Daily ,